A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ANTROQUINONOL IN HOSPITALIZED PATIENTS WITH MILD TO MODERATE PNEUMONIA DUE TO COVID-19

Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2021
This article has no abstract
Epistemonikos ID: e53f986b4f521030239e6d5bb4fb1fae885b1240
First added on: Jul 08, 2021